Caliber Therapeutics
New Hope
About Caliber Therapeutics
Caliber Therapeutics, Inc. engages in the development and commercialization of minimally-invasive balloon-based drug delivery products for the intervention of atherosclerotic diseases. It offers Targeted Angioplasty Drug Delivery balloon, a stent-free delivery platform of anti-restenotic drugs, which enables controlled and targeted drug delivery, reduces thrombosis risk, and reduces the need to implant permanent devices.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.0M
- Last round: Series Unknown (Jun 2017)
- Website: calibertherapeutics.com
- Phone: (215)862-5797
Industries & Categories
Biotechnology, Delivery, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/caliber-therapeutics-198671 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.